Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis?

Habib Haybar1, Seyed Mohammad Sadegh Pezeshki2, Najmaldin Saki2

  • 1Atherosclerosis research center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Insights

Complete blood count (CBC) indices like red cell distribution width (RDW) and mean platelet volume (MPV) are valuable prognostic biomarkers for cardiovascular diseases (CVDs). Inflammatory markers also aid in predicting CVD prognosis.

Area of Science:

  • Hematology
  • Cardiology
  • Internal Medicine

Background:

  • Complete blood count (CBC) indices are increasingly studied for their correlation with cardiovascular diseases (CVDs).
  • Existing research on the prognostic value of CBC parameters in CVDs is dispersed.
  • This review synthesizes findings on CBC indices and CVD prognosis for the first time.

Purpose of the Study:

  • To review and summarize the prognostic value of CBC parameters in cardiovascular diseases.
  • To consolidate dispersed research findings into a comprehensive overview.
  • To highlight key CBC indices as potential biomarkers for CVD prognosis.

Main Methods:

  • Literature search of English language studies from 1996-2018.
  • Databases searched include Google Scholar and PubMed.
  • Keywords used: "Complete blood count", "Cardiovascular disease", "Red cell distribution width", "Mean platelet volume".

Main Results:

  • Red cell distribution width (RDW) is an independent prognostic biomarker for various CVDs.
  • Mean platelet volume (MPV) is another significant prognostic biomarker for CVDs.
  • Elevated inflammatory markers like neutrophil-to-lymphocyte ratio (NLR) indicate poor prognosis in CVD patients, particularly in myocardial infarction and heart failure.

Conclusions:

  • RDW serves as a valuable independent biomarker for assessing prognosis in heart failure, atherosclerosis, and myocardial infarction.
  • MPV increases are reliable prognostic and diagnostic indicators for CVDs like myocardial infarction and unstable angina.
  • Inflammatory markers including white blood cell count, NLR, monocyte to HDL ratio (MHR), and platelet to lymphocyte ratio (PLR) are valuable for predicting prognosis across various CVDs.
Abstract

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
429
Indicators02:39

Indicators

Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
59.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
820
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
574
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
562